Moderna said it plans to seek emergency use authorization from the U.S. Food and Drug Administration for its COVID-19 vaccine in children under age 6 'in the coming weeks.' ABC News' Med Unit producer Sony Salzman breaks it down.
The vaccine in children is a two-dose, 25-microgram shot, about a quarter of the dose used for adults, given 28 days apart.A vial filled with the Moderna COVID-19 vaccine rests by syringes waiting to be loaded by nurses from the Jackson-Hinds Comprehensive Health Center, at a vaccination station next to Jackson State University in Jackson, Miss., Dec. 7, 2021.
During the omicron surge, there were enough children infected in the clinical trial to estimate two doses of the vaccine were 44% effective against any COVID-19 infection, including asymptomatic and mild infections, for children aged 6 months to 2 years, Moderna said. The vaccine was also 38% effective among kids aged 2 to 6.
“We believe these latest results from the ... study are good news for parents of children under 6 years of age," Stéphane Bancel, CEO of Moderna, said in a statement."Given the need for a vaccine against COVID-19 in infants and young children, we are working with the U.S. FDA and regulators globally to submit these data as soon as possible."Currently, Pfizer has the only vaccine available for U.S. children -- but only for kids as young as 5.
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
Moderna wants the FDA to authorize its COVID-19 vaccine for kids under 6The company will submit a request to the Food and Drug Administration “in the coming weeks” for authorization for a two-dose shot for younger kids.
Baca lebih lajut »
Moderna wants the FDA to authorize its COVID-19 vaccine for kids under 6Moderna wants the FDA to authorize its COVID-19 vaccine for kids under six. Here's what's next in the process. | via NPR
Baca lebih lajut »
Moderna wants the FDA to authorize its COVID-19 vaccine for kids under 6 - Alaska Public MediaModerna is hoping to get the green light to administer a pediatric, low-dose COVID-19 vaccine for children ages 6 months to under 6 years of age.
Baca lebih lajut »
FDA details problems at plant behind recalled baby formulaFederal safety inspectors say baby formula maker Abbott failed to maintain sanitary conditions at the Michigan manufacturing plant recently linked to a cluster of infant illnesses.
Baca lebih lajut »
FDA reveals details about what went wrong with baby formula linked to infant deathsAbbott didn’t maintain clean surfaces used in producing and handling the powdered formula, according to the FDA inspection, which concluded last week.
Baca lebih lajut »